Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole duration after tamoxifen in postmenopausal breast cancer
NCT00301457Phase 3Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Jun 2006
- Primary completion
- Apr 2022
- Countries
- 1
01
Overview
A Phase 3 trial of anastrozole in breast cancer, sponsored by Maastricht University Medical Center+. Started Jun 2006; status: completed.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00301457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00301457.